SGRY 13F position history: Howard Marks - Oaktree Capital Management
Surgery Partners, Inc, as reported in Howard Marks - Oaktree Capital Management’s quarterly 13F filings. See all fund managers holding SGRY.
| Quarter | Activity | Shares | Value | % of portfolio | Reported price | |
|---|---|---|---|---|---|---|
| Q2 2026 | New | 862,588 | $14,491,478 | 0.38% | $16.80 | Filing |